NZX · NZX:CVT
Comvita Limited
listed · Honey · FY-end 06-30
NZX-listed mānuka honey and bee-product company (not USX). Earnings track honey harvest, inventory and China/retail demand — a different cycle from dairy. FY-end is 30 June. Reported NPAT in FY24–FY25 was dominated by impairments and inventory write-downs; HY26 returned to a small statutory profit. Read underlying/normalised EBIT in the company pack alongside statutory NPAT.
- Cadence
- Annual, Interim
- Last reported
- FY26 · 28 Aug 2026
- Next window (est.)
- Interim · late Feb 2027
Latest numbers · FY26
Return to statutory profit after FY25 impairments. Ended the year with $0.5m net cash after recapitalisation.
- Revenue
- $213m
- NPAT
- $7.7m
- Operating profit
- $14.0m
- Underlying EBITDA
- $25.4m
- Net debt
- −$0.5m
History
Reports & sources
-
FY26 · Annual
Announced 28 Aug 2026 · period ended 30 Jun 2026
Return to statutory profit after FY25 impairments. Ended the year with $0.5m net cash after recapitalisation.
Revenue $213m · NPAT $7.7m · Operating profit $14.0m · Underlying EBITDA $25.4m · Net debt −$0.5m
-
HY26 · Interim
Announced 23 Feb 2026 · period ended 31 Dec 2025
Return to statutory profit. Normalised EBIT $10.0m.
Revenue $118m · NPAT $4.6m
-
FY25 · Annual
Announced 27 Aug 2025 · period ended 30 Jun 2025
Reported NPAT includes $53.9m impairments and $15.1m inventory provisions. Underlying NBT about −$21.9m.
Revenue $192m · NPAT −$105m
-
FY24 · Annual
Announced 29 Aug 2024 · period ended 30 Jun 2024
Reported NPAT includes a large non-cash impairment. Underlying NPAT about −$9.3m.
Revenue $204m · NPAT −$77.4m · Net debt $79.7m